Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Latoma 2.5mg Tablet
Manufacturer/Marketed By : AXIOMMAX ONCOLOGY PVT LTD
$4.79 $3.37
Latoma 2.5mg Tablet is an anti-cancer drug that belongs to the class aromatase inhibitor. It is indicated as a supportive therapy after the main therapy or first-line therapy for postmenopausal...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
LETROZOLE
Active Pharmaceutical Ingredient
Latoma 2.5mg Tablet
4,79 $US
3,37 $US
Latoma 2.5mg Tablet is an anti-cancer drug that belongs to the class aromatase inhibitor. It is indicated as a supportive therapy after the main therapy or first-line therapy for postmenopausal women with early and advanced breast cancer whose tumors are hormone receptor-positive. Since high amounts of estrogen are found to trigger breast cancer, this medicine reduces the levels of the female reproductive hormone by blocking the enzyme (aromatase) that is involved in the production of estrogen. This medicine aims to slow or stop the growth and/or spreading to other body parts. Inform your physician if you have not attained menopause yet, as this medicine does not work for premenopausal women. Since this medicine tends to reduce the levels of female reproductive hormones, it is not advised for menstruating women as it is related to causing fertility issues. It is advised to keep track of your cholesterol levels as this medicine tends to elevate them. This medicine could also decrease bone mineral density. Hence, discuss with your physician and consider monitoring your bone parameters regularly. It is advised to use effective birth control during the treatment and at least 3 weeks after the last dose.
Active Pharmaceutical Ingredient
Uses
• First and second-line treatment of postmenopausal women with hormone receptor-positive breast cancer.
• Supportive to standard treatment for postmenopausal women with early breast cancer.
• Treatment for unknown advanced breast cancer in postmenopausal women.
• Extended supportive therapy for postmenopausal women with early breast cancer who have already taken other anti-cancer medication.
Benefits
The growth of some cancers of breasts are stimulated by estrogens. Latoma 2.5mg Tablet is a nonsteroidal compound that inhibits estrogen production by blocking the enzyme aromatase. This medicine reduces the tumor size and stops or slows the progression of the disease, avoiding the reoccurring of early-stage breast cancer and improving the survival rate.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Swelling in the face, eyes, feet, and legs
• Hot sweats and excessive sweating
• Hypercholesterolemia (high cholesterol)
• Constipation
• Heart papilation
• Hypertension
• Diarrhea
• Loss of appetite
• Nausea and Vomiting
• Muscle pain, bone pain, and joint stiffness
• Dizziness, tiredness, and sleepiness
• Breathing difficulty
• Arthralgia
Common Side Effects
• Decreased red blood cells
• Decreased bone mineral density
• Fluid buildup in lungs
How To Use
It is advised to consume Latoma 2.5mg Tablet exactly as your doctor prescribes. It can be consumed with or without food and should be swallowed with a glass of water. Latoma 2.5mg Tablet can be taken with or without food. It is better to take the tablet at a fixed time. Do not break, chew or crush the tablet.
Safety Advice
• Breast Feeding: It is not safe to breastfeed your baby when you are taking a Latoma 2.5mg Tablet. It is advised to avoid breastfeeding for at least three weeks after the last dose of the medicine.
• Alcohol: It is not recommended to consume alcohol while you are on the treatment with a Latoma 2.5mg Tablet as it may cause serious complications.
• Liver: Inform your physician if you have liver disease, as the Latoma 2.5mg Tablets are not recommended for patients with severe liver disease. Dose adjustment may be required.
• Lungs: Certain lung diseases can occur while using Latoma 2.5mg Tablet. Consult your doctor if you have lung diseases.
• Driving: Caution is required while driving and operating machinery when you take a Latoma 2.5mg Tablet causes dizziness, sleepiness, and tiredness.
• Pregnancy: Latoma 2.5mg Tablet are highly unsafe during pregnancy because they may cause harm to the unborn baby. It is better to discuss with a doctor the use of an effective contraceptive method during the Latoma 2.5mg Tablet treatment if you still have the potential to become pregnant. It is recommended to consult your physician if you are pregnant already or suspect pregnancy.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.